February 6: Report Commissioned by COA Explores “Murky” World of Pharmacy DIR Fees
A white paper commissioned by the Community Oncology Alliance (COA) delved into the practice of “direct and indirect remuneration” (DIR) fees administered by pharmacy benefit managers (PBMs) and how they could drive up drug prices for Medicare Part D beneficiaries and taxpayers. – See more at: http://www.ajmc.com/newsroom/report-commissioned-by-coa-explores-murky-world-of-pharmacy-dir-fees#sthash.ufFvicZD.dpuf
February 6: Report Commissioned by COA Explores “Murky” World of Pharmacy DIR Fees
A white paper commissioned by the Community Oncology Alliance (COA) delved into the practice of “direct and indirect remuneration” (DIR) fees administered by pharmacy benefit managers (PBMs) and how they could drive up drug prices for Medicare Part D beneficiaries and taxpayers. – See more at: http://www.ajmc.com/newsroom/report-commissioned-by-coa-explores-murky-world-of-pharmacy-dir-fees#sthash.ufFvicZD.dpuf
